primary pulmonary hypertension

Cytopia Appoints Study Chairman for JAK2 Clinical Trial - MarketWatch (Primary Pulmonary Hypertension News)

July 30th, 2008


Cytopia Appoints Study Chairman for JAK2 Clinical Trial
MarketWatch - 11 hours ago
particularly lymphomas and solid tumours where JAK2 has been shown to be upregulated, and for cardiovascular diseases such as pulmonary hypertension.

Read More…


Source: In Collaboration With the National Heart, Lung, and Blood
Cardiosource, DC - Jul 28, 2008
There is an increased prevalence of OSA in pulmonary arterial hypertension, but OSA is not a common cause of severe pulmonary hypertension,

Read More…


New drug - Volibris
Healthcare Republic (press release), UK - Jul 29, 2008
GSK has launched Volibris (ambrisentan) for the treatment of pulmonary arterial hypertension (WHO Class II and III) to improve exercise capacity.

Read More…


Study says prevention key in fighting chronic diseases
Gloucester County Times - NJ.com, NJ - 7 hours ago
The top chronic diseases heart disease, cancers, mental disorders, pulmonary conditions, hypertension, diabetes and stroke also cost the nation hundreds of
Annual Economic Impact of Chronic Disease on New Jersey Economy Is MarketWatch
Chronic illnesses sicken state's economy, report finds The Star-Ledger - NJ.com
Report: 7 chronic illnesses cost NJ $39B per year The Star-Ledger - NJ.com
all 11 news articles

Read More…


Elan and Wyeth Present Encouraging Results from Phase 2 Clinical
MarketWatch - 14 hours ago
The pre-specified primary efficacy endpoints were change from baseline in Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-cog) and Disability

Read More…

Posted in primary pulmonary hypertension | No Comments »


First half 2008 financial results: NicOx nears completion of phase … - FOXBusiness (Primary Pulmonary Hypertension News)

July 28th, 2008


First half 2008 financial results: NicOx nears completion of phase
FOXBusiness - 9 hours ago
The two studies have recruited a total of 417 osteoarthritis patients with controlled hypertension and results are projected in the fourth quarter of 2008.

Read More…


Bosentan Improves Quality Of Life For Patients With Pulmonary
Science Daily (press release) - Jul 24, 2008
2008) — Recent studies have shown that bosentan therapy greatly improves the quality of life for patients with pulmonary arterial hypertension (PAH).

Read More…


Kentucky Children's Heart Center Opens
UK News, KY - 6 hours ago
invasive electrophysiological study and ablation of abnormal electrical pathways; pulmonary hypertension; preventive cardiology; and cardiomyopathy.

Read More…


Source: In Collaboration With the National Heart, Lung, and Blood
Cardiosource, DC - 2 hours ago
There is an increased prevalence of OSA in pulmonary arterial hypertension, but OSA is not a common cause of severe pulmonary hypertension,

Read More…


Viagra - New Uses
HULIQ (press release), NC - 3 hours ago
The 2nd new use for Viagra is to treat babies who are born with pulmonary hypertension. Because Viagra allows more blood to flow to lung vessels,

Read More…

Posted in primary pulmonary hypertension | No Comments »


Financial Results for Full Year 2007: NicOx Significantly Advances - PR Newswire (Primary Pulmonary Hypertension News)

July 28th, 2008

SOPHIA ANTIPOLIS, France, March 3 /PRNewswire-FirstCall/ — NicOx S.A. Euronext: COX Paris: COX today announced its financial results for 2007 and provided an overview of its activities during the year. NicOx also announced today the initiation of Read More

- 430 abstracts from studies involving Taxotere(R) or Eloxatin(R) accepted at the meeting’s scientific sessions - BRIDGEWATER, N.J., May 31 /PRNewswire-FirstCall/ — Sanofi-aventis U.S. announced today that key study results from the company’s Read More

- access, resources and health services coverage. Selected indicators are disaggregated into age groups, sex and/or urban/rural region. Generated tables can be exported and printed. The data presented is updated annually with the latest country Read More

Then again, maybe not. Americans spend $30 billion a year on weight-loss programs, but obesity resists treatment more tenaciously than do viruses–90 percent to 95 percent of people who lose weight eventually regain it. Why is that? We’ve learned Read More

Survival analysis (6-year median follow-up) of the MOSAIC study presented at this year’s ASCO CHICAGO, June 3 /PRNewswire-FirstCall/ — FOLFOX4, an Eloxatin(R) (oxaliplatin injection)-based chemotherapy regimen, significantly improved the overall Read More

Posted in primary pulmonary hypertension | No Comments »


Some Florida babies are on the "little blue pill" - ABC7Chicago.com (Primary Pulmonary Hypertension News)

July 26th, 2008


Some Florida babies are on the "little blue pill"
ABC7Chicago.com,  USA - 15 hours ago
They call it a wonder drug for babies born with pulmonary hypertension. Since babies can't swallow the pill, pharmacists have to crush it and give it to

Read More…


Viagra proves effective in treating medical condition in infants
KTKA.com, KS - 21 hours ago
He says Viagra is a wonder drug for babies who were born with pulmonary hypertension. "As the blood flow goes to the lung, the arteries in the lung become

Read More…

Posted in primary pulmonary hypertension | No Comments »


New Eloxatin(R) and Taxotere(R) Data in Several Tumor Types to Be - PR Newswire (Primary Pulmonary Hypertension News)

July 26th, 2008

- 430 abstracts from studies involving Taxotere(R) or Eloxatin(R) accepted at the meeting’s scientific sessions - BRIDGEWATER, N.J., May 31 /PRNewswire-FirstCall/ — Sanofi-aventis U.S. announced today that key study results from the company’s Read More

- access, resources and health services coverage. Selected indicators are disaggregated into age groups, sex and/or urban/rural region. Generated tables can be exported and printed. The data presented is updated annually with the latest country Read More

Posted in primary pulmonary hypertension | No Comments »


Charles E. Triano - Senior Vice President, Investor Relations - Seeking Alpha (Primary Pulmonary Hypertension News)

July 25th, 2008


Charles E. Triano - Senior Vice President, Investor Relations
Seeking Alpha, NY - Jul 23, 2008
we also added Thelin, a once daily oral treatment for pulmonary arterial hypertension which is already approved in Europe, Canada and Australia.

Read More…


Bosentan Improves Quality Of Life For Patients With Pulmonary
Science Daily (press release) - 11 hours ago
2008) — Recent studies have shown that bosentan therapy greatly improves the quality of life for patients with pulmonary arterial hypertension (PAH).

Read More…


BBC News

Australian expert says abuse of legal drugs could mar Beijing
CNN - 5 hours ago
Viagra also is approved to treat pulmonary hypertension, a condition in which the lungs' blood vessels tighten. Doctors have used the drug experimentally to
Read this article online at: # Melbourne Herald Sun
all 79 news articles

Read More…


Pulmonary Arterial Hypertension More Severe in Carriers of BMPR2
Abkhazia, CA - 6 hours ago
Among patients with pulmonary arterial hypertension (PAH), those with germline mutations in the gene encoding bone morphogenetic protein receptor 2 (BMPR2)

Read More…


Organ Donation Finding Place Online in Several States
RedOrbit, TX - 11 hours ago
He now manages his pulmonary hypertension with medication, but he knows he could be back on those lists if his condition deteriorates.

Read More…

Posted in primary pulmonary hypertension | No Comments »


FDA Updates Healthcare Professionals about Recent Changes Made to … - PharmaLive.com (press release) (Primary Pulmonary Hypertension News)

July 24th, 2008


FDA Updates Healthcare Professionals about Recent Changes Made to
PharmaLive.com (press release), PA - Jul 18, 2008
Patients with pulmonary hypertension or unstable cardiopulmonary conditions should have their vital signs and cutaneous oxygen saturation monitored during

Read More…


Charles E. Triano - Senior Vice President, Investor Relations
Seeking Alpha, NY - 18 hours ago
we also added Thelin, a once daily oral treatment for pulmonary arterial hypertension which is already approved in Europe, Canada and Australia.

Read More…


MLive.com

Executive Profile: Dr. Benjamin M. Rossi, medical director of the
MLive.com, MI - 10 hours ago
A tool that's emerging quickly for that continuity of care is TeleHomecare, remote monitoring for heart failure, hypertension, chronic obstructive pulmonary

Read More…

Posted in primary pulmonary hypertension | No Comments »


Your Health This Week - Slate (Primary Pulmonary Hypertension News)

July 22nd, 2008

Then again, maybe not. Americans spend $30 billion a year on weight-loss programs, but obesity resists treatment more tenaciously than do viruses–90 percent to 95 percent of people who lose weight eventually regain it. Why is that? We’ve learned Read More

IRVINE, Calif., Feb. 20 /PRNewswire/ — LifeMasters Supported SelfCare, Inc., a national provider of health improvement services, announced that it has received an extension from the Centers for Medicare & Medicaid Services (CMS) of its disease Read More

Posted in primary pulmonary hypertension | No Comments »


Bosentan Improves Quality of Life for Patients with Pulmonary … - innovations report (Primary Pulmonary Hypertension News)

July 22nd, 2008


Bosentan Improves Quality of Life for Patients with Pulmonary
innovations report, Germany - Jul 18, 2008
Recent studies have shown that bosentan therapy greatly improves the quality of life for patients with pulmonary arterial hypertension (PAH).

Read More…


NicOx completes enrollment of two Ambulatory Blood Pressure
MarketWatch - 7 hours ago
NicOx SA (Euronext Paris: COX) today announced it has successfully completed the enrollment of 417 osteoarthritis (OA) patients with controlled hypertension

Read More…

Posted in primary pulmonary hypertension | No Comments »


Influenza Guidelines Updated CME/CE - Medscape News (Primary Pulmonary Hypertension News)

July 21st, 2008

Physicians - maximum of 0.25 AMA PRA Category 1 Credit(s) ™ for physicians; Family Physicians - up to 0.25 AAFP Prescribed credit(s) for physicians; Nurses - 0.25 nursing contact hours (0.25 contact hours are in the area of pharmacology) To Read More

Does Ezetimibe ENHANCE the Benefits of Statins? Old Diseases Make News An Erythropoietin-Stimulating Agent for Cancer-Related Anemia - No Benefit A New Approach to Osteoporosis and Fracture Risk Survival Rate From In-Hospital Cardiac Read More

- access, resources and health services coverage. Selected indicators are disaggregated into age groups, sex and/or urban/rural region. Generated tables can be exported and printed. The data presented is updated annually with the latest country Read More

Then again, maybe not. Americans spend $30 billion a year on weight-loss programs, but obesity resists treatment more tenaciously than do viruses–90 percent to 95 percent of people who lose weight eventually regain it. Why is that? We’ve learned Read More

Posted in primary pulmonary hypertension | No Comments »